Skip to main content
. 2019 Nov 1;44(4):e42. doi: 10.5395/rde.2019.44.e42

Table 1. List of antiresorptive drugs.

Generic name Brand name Manufacture Dosage (application) Indication
Bisphosphonate
Zoledronic acid Zometa Novartis pharmaceuticals (Novartis Korea) 4 mg/100 mL (IV) Hypercalcemia of malignancy, bone complication due to multiple myeloma and bone metastases from solid tumors
Reclat/Aclasta 5 mg/100 mL (IV) Osteoporosis, Paget's disease
Alendronate sodium Fosamax Merck & Co. (MSD Korea) 1, 10, 35, 40, 70 mg (PO) Osteoporosis, Paget's disease
Fosamax Plus D 70 mg (PO) Osteoporosis
Ibandronate sodium Boniva/Bonviva Genentech/Roche (Roche Korea) 150 mg (PO) Osteoporosis
3 mg (IV) Osteoporosis
Bonviva plus (Alvogen Korea) 150 mg (PO) Osteoporosis
Risedronate sodium Actonel Warner Chilcott (Handok) 5, 35, 75, 150 mg (PO) Osteoporosis, Paget's disease
Clodronate disodium Bonefos Bayer 400, 800 mg (PO) Osteoporosis, hypercalcemia and osteolysis due to malignancy
Paget's disease, hypercalcemia due to metastatic bone disease, multiple myeloma
Tiludronate disodium Skelid Sanofi-Aventis 240 mg (PO) Paget's disease
Pamidronate disodium Aredia Novatis Pharmaceuticals (Novartis Korea) 30, 60, 90 mg (IV) Hypercalcemia with malignancy, bone metastases, Paget's disease
Denosumab Prolia Amgen (Amgen Korea) 60 mg (SC) Osteoporosis
Xgeva 120 mg (SC) Skeletal related event with bone metastases

IV, intravenous injection; PO, per os; SC, subcutaneous injection.